Concentration‐dependent clinical and prognostic importance of high‐sensitivity cardiac troponin T in heart failure and a reduced ejection fraction and the influence of empagliflozin: the EMPEROR‐Reduced trial

AIMS: Circulating troponin is an important measure of risk in patients with heart failure, but it has not been used to determine if disease severity influences the responses to drug treatments in randomized controlled trials. METHODS AND RESULTS: In the EMPEROR‐Reduced trial, patients with class II–...

Descripción completa

Detalles Bibliográficos
Autores principales: Packer, Milton, Januzzi, James L., Ferreira, Joao Pedro, Anker, Stefan D., Butler, Javed, Filippatos, Gerasimos, Pocock, Stuart J., Brueckmann, Martina, Jamal, Waheed, Cotton, Daniel, Iwata, Tomoko, Zannad, Faiez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2021
Materias:
Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291909/
https://www.ncbi.nlm.nih.gov/pubmed/34053177
http://dx.doi.org/10.1002/ejhf.2256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291909/
https://www.ncbi.nlm.nih.gov/pubmed/34053177
http://dx.doi.org/10.1002/ejhf.2256

Ejemplares similares